Login
$MIRA
$0.56 +$0.01 (1.11%) Close

Company Executives

Officer Age In this role Joined 2025 pay Source
Erez Aminov Also a director
Chief Executive Officer and Chairman
48 Not stated Not stated $5,304,174
Andriy Mushak
Chief Financial Officer
43 Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
5
serving now
Independent
4 of 4
stated in the proxy; 1 not stated
Average tenure
2.2 years
from year joined
CEO also chairs the board
Yes
Erez Aminov
Director Age On board Independent Committees Other public boards Pay Source
Erez Aminov
48 2023
3 years
Not stated None stated Telomir Pharmaceuticals, Inc. (Nasdaq: TELO) Paid as CEO
Matthew Pratt Whalen
47 Not stated Independent
Audit Committee · Chair
Telomir Pharmaceuticals, Inc. (Nasdaq TELO) Not stated
Matthew Paul Del Giudice, M.D.
44 2024
2 years
Independent
Nominating and Corporate Governance Committee · Chair
Telomir Pharmaceuticals, Inc. (Nasdaq TELO) Not stated
Denil Nanji Shekhat, M.D.
45 2024
2 years
Independent
Audit Committee Compensation Committee · Chair Nominating and Corporate Governance Committee
None stated Not stated
Edward MacPherson
38 2024
2 years
Independent
Audit Committee Compensation Committee
Telomir Pharmaceuticals, Inc. (Nasdaq TELO) Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Jul 28, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support